WASHINGTON (dpa-AFX) - Cepheid (CPHD) announced that the U.S. Food & Drug Administration, or FDA, has cleared its GeneXpert Infinity-80 System, a high-throughput automated molecular system designed to deliver around-the-clock results for a wide variety of clinical testing applications. The GeneXpert Infinity-80 has been initially cleared in conjunction with Cepheid's Xpert Flu test.
The GeneXpert Infinity-80 System will be available for shipment on July 1, the company noted.
John Bishop, Cepheid's chief executive officer, stated, 'With the capability of generating more than two thousand automated results per day, the GeneXpert Infinity-80 is the most efficient, highest throughput molecular diagnostic system on the market - delivered in the same footprint as our current Infinity-48 System. The Infinity-80 also offers a user experience that's generations ahead of alternative solutions - enabling true walk-away ease-of-use and minimal hands-on time.'
Copyright RTT News/dpa-AFX
© 2012 AFX News
